How long does vancomycin stay in your body?

Vancomycin is a well-known antibiotic used to treat severe bacterial infections. This powerful medication can be given intravenously or orally. Vancomycin has a complicated pharmacokinetic profile that is dependent on many factors such as the patient’s body weight, age, kidney function, and severity of the infection. The question that many people ask is how long does vancomycin stay in your body? In this article, we’ll explore the answer to this question in detail.

The Pharmacokinetics of Vancomycin

Before we dive into how long vancomycin stays in your body, let’s briefly discuss its pharmacokinetics. Pharmacokinetics is the study of how drugs are absorbed, distributed, metabolized, and eliminated by the body. Understanding the pharmacokinetics of vancomycin is essential to determining how long it stays in your body.

Absorption

Vancomycin is not absorbed well when taken orally. Therefore, it is typically administered intravenously. When given intravenously, it is rapidly distributed to body tissues.

Distribution

Vancomycin has a large volume of distribution, which means that it distributes widely throughout the body. This is because vancomycin is highly protein-bound and can easily cross cell membranes. It can cross the blood-brain barrier and enter the cerebrospinal fluid, making it useful for treating meningitis.

Metabolism

Vancomycin is not metabolized in the body; it is eliminated unchanged by the kidneys.

Elimination

The elimination of vancomycin from the body is dependent on renal function. Kidney function is typically measured by creatinine clearance. When kidney function is normal, about 90% of the drug is eliminated from the body within 24 hours. However, if kidney function is impaired, the clearance of vancomycin decreases, leading to prolonged elimination times.

Factors That Affect Vancomycin Elimination

Body Weight

Vancomycin is primarily eliminated by the kidneys; therefore, it follows that patients with a larger body weight may eliminate the drug more quickly. This is because the kidneys of larger patients have a greater surface area for drug elimination.

Kidney Function

As previously mentioned, kidney function is a significant factor in vancomycin elimination. Patients with normal kidney function typically eliminate the drug quickly. However, in patients with renal impairment, the clearance of vancomycin decreases, leading to prolonged elimination times.

Age

Age can affect vancomycin elimination. As people age, their kidney function typically decreases, which can lead to prolonged elimination times. Therefore, older patients may eliminate vancomycin more slowly than younger patients.

Severity of Infection

The severity of the infection being treated can also affect how long vancomycin stays in the body. Patients with severe infections may require higher doses of vancomycin or a more extended course of treatment. This can also lead to prolonged elimination times.

How Long Does Vancomycin Stay in Your Body?

The half-life of vancomycin is about 6 hours in patients with normal kidney function. Therefore, if a patient is given a standard dose of vancomycin, it should be eliminated from the body within 24 hours. However, this is dependent on kidney function, body weight, and age. In patients with impaired kidney function, the clearance of vancomycin may be significantly decreased, leading to prolonged elimination times.

Monitoring Vancomycin Levels

Vancomycin levels should be monitored carefully in patients receiving the drug. This is particularly important in patients with impaired kidney function. Monitoring vancomycin levels can help to ensure that the drug is eliminated at an appropriate rate and that the patient is receiving an effective dose.

Trough Levels

Trough levels of vancomycin can be measured to ensure that the drug is not being overused or underdosed. Trough levels are typically measured just before the next dose is given. If the trough level is too low, it may indicate that the patient is not receiving an adequate dose, and if the trough level is too high, it may indicate that the patient is being given too much drug.

Peak Levels

Peak levels of vancomycin can also be measured to determine if the patient is receiving an appropriate dose of the drug. Peak levels are typically measured about an hour after the dose is given. Too high of a peak level can lead to toxic side effects, and too low a peak level may indicate that the patient is not receiving an adequate dose of vancomycin.

Conclusion

Vancomycin is a powerful antibiotic used to treat severe bacterial infections. How long it stays in your body is dependent on a variety of factors such as body weight, kidney function, age, and the severity of the infection. Patients with normal kidney function typically eliminate the drug within 24 hours. However, in patients with impaired kidney function or other factors that affect elimination, the clearance of vancomycin may be significantly decreased, leading to prolonged elimination times. It is important to monitor vancomycin levels carefully to ensure that patients receiving the drug are not experiencing toxic side effects and are receiving an appropriate dose.

FAQs

  • Q: What is vancomycin used for?
    • A: Vancomycin is an antibiotic used to treat severe bacterial infections such as methicillin-resistant S. aureus (MRSA) infections, sepsis, and endocarditis.
  • Q: How is vancomycin taken?
    • A: Vancomycin can be given intravenously or orally. When given intravenously, it is typically injected into a vein over 1-2 hours.
  • Q: How long does it take for vancomycin to start working?
    • A: Vancomycin begins working immediately after it is administered. However, it may take a few days for the patient to start feeling better.
  • Q: What are the side effects of vancomycin?
    • A: Common side effects of vancomycin include nausea, vomiting, diarrhea, fever, chills, and headache. Rare but serious side effects include kidney damage and hearing loss.
  • Q: Who should not take vancomycin?
    • A: Vancomycin should not be given to patients who are allergic to the drug or who have a history of kidney damage or hearing loss.

References

1. Vancomycin. (2019, November 1). In DynaMed. Retrieved September 30, 2021, from https://www.dynamed.com/drug-monograph/vancomycin.

2. Vancomycin. (2021, March 11). In Lexicomp. Retrieved September 30, 2021, from https://www.lexicomp.com/drug-information/vancomycin/.

3. Vancomycin (Oral Route, Intravenous Route). (2021, July 1). In Mayo Clinic. Retrieved September 30, 2021, from https://www.mayoclinic.org/drugs-supplements/vancomycin-oral-route-intravenous-route/description/drg-20068071.